33 research outputs found
Search for Kaluza-Klein Graviton Emission in Collisions at TeV using the Missing Energy Signature
We report on a search for direct Kaluza-Klein graviton production in a data
sample of 84 of \ppb collisions at = 1.8 TeV, recorded
by the Collider Detector at Fermilab. We investigate the final state of large
missing transverse energy and one or two high energy jets. We compare the data
with the predictions from a -dimensional Kaluza-Klein scenario in which
gravity becomes strong at the TeV scale. At 95% confidence level (C.L.) for
=2, 4, and 6 we exclude an effective Planck scale below 1.0, 0.77, and 0.71
TeV, respectively.Comment: Submitted to PRL, 7 pages 4 figures/Revision includes 5 figure
Measurement of the average time-integrated mixing probability of b-flavored hadrons produced at the Tevatron
We have measured the number of like-sign (LS) and opposite-sign (OS) lepton
pairs arising from double semileptonic decays of and -hadrons,
pair-produced at the Fermilab Tevatron collider. The data samples were
collected with the Collider Detector at Fermilab (CDF) during the 1992-1995
collider run by triggering on the existence of and candidates
in an event. The observed ratio of LS to OS dileptons leads to a measurement of
the average time-integrated mixing probability of all produced -flavored
hadrons which decay weakly, (stat.)
(syst.), that is significantly larger than the world average .Comment: 47 pages, 10 figures, 15 tables Submitted to Phys. Rev.
Measurement of the polar-angle distribution of leptons from W boson decay as a function of the W transverse momentum in proton-antiproton collisions at sqrt{s}=1.8 TeV
We present a measurement of the coefficient alpha_2 of the leptonic
polar-angle distribution from W boson decays, as a function of the W transverse
momentum. The measurement uses an 80+/-4 pb^{-1} sample of proton-antiproton
collisions at sqrt{s}=1.8 TeV collected by the CDF detector and includes data
from both the W->e+nu and W->mu+nu decay channels. We fit the W boson
transverse mass distribution to a set of templates from a Monte Carlo event
generator and detector simulation in several ranges of the W transverse
momentum. The measurement agrees with the Standard Model expectation, whereby
the ratio of longitudinally to transversely polarized W bosons, in the
Collins-Soper W rest frame, increases with the W transverse momentum at a rate
of approximately 15% per 10 GeV/c.Comment: 47 pages, 16 figures, submitted to Physical Review
Study of multi-muon events produced in p\bar{p} interactions at \sqrt{s}=1.96 TeV
68 pages, 46 figures, 11 tables. Submitted to Phys. Rev. D. Removed typos from the authors' listWe report the results of a study of multi-muon events produced at the Fermilab Tevatron collider and acquired with the CDF II detector using a dedicated dimuon trigger. The production cross section and kinematics of events in which both muon candidates are produced inside the beam pipe of radius 1.5 cm are successfully modeled by known processes which include heavy flavor production. In contrast, we are presently unable to fully account for the number and properties of the remaining events, in which at least one muon candidate is produced outside of the beam pipe, in terms of the same understanding of the CDF II detector, trigger, and event reconstruction.Peer reviewe
A study of the associated production of photons and b-quark jets in p-pbar collisions at sqrt{s} = 1.96 TeV
submitted to PRLThe cross section for photon production in association with at least one jet containing a -quark hadron has been measured in proton antiproton collisions at TeV. The analysis uses a data sample corresponding to an integrated luminosity of 340 pb collected with the CDF II detector. Both the differential cross section as a function of photon transverse energy , (-jet)/ and the total cross section (-jet; GeV) are measured. Comparisons to a next-to-leading order prediction of the process are presented.The cross section for photon production in association with at least one jet containing a b quark has been measured in proton antiproton collisions at √s=1.96 TeV. The data sample used corresponds to an integrated luminosity of 340 pb-1 collected with the CDF II detector. Both the differential cross section as a function of photon transverse energy ETγ and the total cross section are measured and compared to a next-to-leading order prediction for the process.Peer reviewe
Measurement of the Ratio of b Quark Production Cross Sections in Antiproton-Proton Collisions at 630 GeV and 1800 GeV
We report a measurement of the ratio of the bottom quark production cross
section in antiproton-proton collisions at 630 GeV to 1800 GeV using bottom
quarks with transverse momenta greater than 10.75 GeV identified through their
semileptonic decays and long lifetimes. The measured ratio
sigma(630)/sigma(1800) = 0.171 +/- .024 +/- .012 is in good agreement with
next-to-leading order (NLO) quantum chromodynamics (QCD)
Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer.
The Aurora-A kinase regulates cell division, by controlling centrosome biology and spindle assembly. Cancer cells often display elevated levels of the kinase, due to amplification of the gene locus, increased transcription or post-translational modifications. Several inhibitors of Aurora-A activity have been developed as anti-cancer agents and are under evaluation in clinical trials. Although the well-known mitotic roles of Aurora-A point at chromosomal instability, a hallmark of cancer, as a major link between Aurora-A overexpression and disease, recent evidence highlights the existence of non-mitotic functions of potential relevance. Here we focus on a nuclear-localised fraction of Aurora-A with oncogenic roles. Interestingly, this pool would identify not only non-mitotic, but also kinase-independent functions of the kinase. We review existing data in the literature and databases, examining potential links between Aurora-A stabilisation and localisation, and discuss them in the perspective of a more effective targeting of Aurora-A in cancer therapy